Cargando…
Pegylated Liposomal Alendronate Biodistribution, Immune Modulation, and Tumor Growth Inhibition in a Murine Melanoma Model
While tumor-associated macrophages (TAM) have pro-tumoral activity, the ablation of macrophages in cancer may be undesirable since they also have anti-tumoral functions, including T cell priming and activation against tumor antigens. Alendronate is a potent amino-bisphosphonate that modulates the fu...
Autores principales: | Islam, Md. Rakibul, Patel, Jalpa, Back, Patricia Ines, Shmeeda, Hilary, Kallem, Raja Reddy, Shudde, Claire, Markiewski, Maciej, Putnam, William C., Gabizon, Alberto A., La-Beck, Ninh M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527549/ https://www.ncbi.nlm.nih.gov/pubmed/37759709 http://dx.doi.org/10.3390/biom13091309 |
Ejemplares similares
-
Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma model
por: Islam, Md. Rakibul, et al.
Publicado: (2022) -
Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes
por: Gabizon, Alberto, et al.
Publicado: (2023) -
Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients
por: Golan, Talia, et al.
Publicado: (2015) -
Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine
por: La-Beck, Ninh M., et al.
Publicado: (2021) -
The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity
por: Dadpour, Saba, et al.
Publicado: (2022)